Archem Diagnostics is pleased to announce an important milestone in its ongoing transition to the European Union In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR).
IMQ S.p.A., a European Notified Body designated under IVDR (NB 0051), has officially confirmed the receipt of our formal application and the signing of a written agreement in accordance with the applicable IVDR regulatory framework.
An Important Step Toward IVDR Compliance
This official confirmation represents a significant step in our regulatory transition process and reflects our continued commitment to quality, regulatory compliance, and patient safety.
Our Commitment to Quality and Reliability
At Archem Diagnostics, we continuously strive to strengthen our quality management processes and align our diagnostic solutions with evolving international regulatory requirements.
We remain dedicated to providing reliable in vitro diagnostic solutions while maintaining our commitment to product quality, continuous improvement, and customer confidence.